These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10679393)
1. Cloak and dagger in the avoidance of immune surveillance. Pinkoski MJ; Green DR Curr Opin Genet Dev; 2000 Feb; 10(1):114-9. PubMed ID: 10679393 [TBL] [Abstract][Full Text] [Related]
2. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Li-Weber M; Krammer PH Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113 [TBL] [Abstract][Full Text] [Related]
3. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand. Ng CS; Lo ST; Chan JK Hum Pathol; 1999 Jan; 30(1):48-53. PubMed ID: 9923926 [TBL] [Abstract][Full Text] [Related]
4. Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR. Pinti M; Nasi M; Moretti L; Mussini C; Petrusca D; Esposito R; Cossarizza A Ann N Y Acad Sci; 2000; 926():46-51. PubMed ID: 11193040 [TBL] [Abstract][Full Text] [Related]
5. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659 [TBL] [Abstract][Full Text] [Related]
6. Defining CD95 as a tumor suppressor gene. Müschen M; Warskulat U; Beckmann MW J Mol Med (Berl); 2000; 78(6):312-25. PubMed ID: 11001528 [TBL] [Abstract][Full Text] [Related]
8. Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR. Pinti M; Pedrazzi J; Benatti F; Sorrentino V; Nuzzo C; Cavazzuti V; Biswas P; Petrusca DN; Mussini C; De Rienzo B; Cossarizza A FEBS Lett; 1999 Sep; 458(2):209-14. PubMed ID: 10481067 [TBL] [Abstract][Full Text] [Related]
9. Expression of Fas and Fas ligand on spleen T cells of experimental animals after unmodified or leukoreduced allogeneic blood transfusions. Hashimoto MN; Kimura EY; Yamamoto M; Bordin JO Transfusion; 2004 Feb; 44(2):158-63. PubMed ID: 14962305 [TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis. Wilson AD; Redchenko I; Williams NA; Morgan AJ Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701 [TBL] [Abstract][Full Text] [Related]
11. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis. Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719 [TBL] [Abstract][Full Text] [Related]
12. CD95 ligand expression as a mechanism of immune escape in breast cancer. Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943 [TBL] [Abstract][Full Text] [Related]
14. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection. Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536 [TBL] [Abstract][Full Text] [Related]
15. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin. Moers C; Warskulat U; Müschen M; Even J; Niederacher D; Josien R; Koldovsky U; Beckmann MW; Häussinger D Int J Cancer; 1999 Feb; 80(4):564-72. PubMed ID: 9935158 [TBL] [Abstract][Full Text] [Related]
16. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215 [TBL] [Abstract][Full Text] [Related]
17. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Sträter J; Wellisch I; Riedl S; Walczak H; Koretz K; Tandara A; Krammer PH; Möller P Gastroenterology; 1997 Jul; 113(1):160-7. PubMed ID: 9207274 [TBL] [Abstract][Full Text] [Related]
18. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Strand S; Galle PR Mol Med Today; 1998 Feb; 4(2):63-8. PubMed ID: 9547792 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit. Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076 [TBL] [Abstract][Full Text] [Related]
20. Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. Falsig J; Latta M; Leist M J Neurochem; 2004 Jan; 88(1):181-93. PubMed ID: 14675162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]